SEC Filings - Ultragenyx Pharmaceutical Inc.

SEC Filings

Filing date	Description	Form	View
Jun 10, 2021	Report of unscheduled material events or corporate event	8-K	View HTML 0000950170-21-000334.pdf 0000950170-21-000334.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
May 19, 2021	Report of unscheduled material events or corporate event	8-K	View HTML 0000950170-21-000281.pdf 0000950170-21-000281.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
May 14, 2021	Report of unscheduled material events or corporate event	8-K	View HTML 0000950170-21-000231.pdf 0000950170-21-000231.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
May 10, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-21-031387.pdf 0001209191-21-031387.xls
May 10, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-21-031384.pdf 0001209191-21-031384.xls
May 10, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-21-031383.pdf 0001209191-21-031383.xls
May 10, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-21-031376.pdf 0001209191-21-031376.xls
May 10, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-21-031386.pdf 0001209191-21-031386.xls
May 10, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-21-031378.pdf 0001209191-21-031378.xls
May 10, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-21-031388.pdf 0001209191-21-031388.xls

INVESTORS & MEDIA

SHAREHOLDER TOOLS